Tigecycline May Selectively Target Leukemic Stem Cells in CML [Research Watch]

Tigecycline inhibits mitochondrial oxidative phosphorylation to target leukemic stem cells (LSC).

from Cancer via ola Kala on Inoreader http://ift.tt/2yfegi7
via IFTTT